• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病腹水患者的快速利尿:外周水肿的重要性。

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.

作者信息

Pockros P J, Reynolds T B

出版信息

Gastroenterology. 1986 Jun;90(6):1827-33. doi: 10.1016/0016-5085(86)90249-0.

DOI:10.1016/0016-5085(86)90249-0
PMID:3699402
Abstract

Serial measurements of plasma volume and ascites volume were made during treatment with large doses of oral diuretics in 14 patients with stable chronic liver disease. Eight patients had pitting edema in addition to ascites. Reproducibility of ascites and plasma volume measurements was verified in 10 control subjects not receiving diuretics. Six patients without edema undergoing rapid diuresis lost a mean of 1.2 +/- 0.2 L of ascites and an equivalent amount of weight (1.3 +/- 0.4 kg) per day. All had a rise in blood urea nitrogen or creatinine, or both, and a fall in creatinine clearance. Eight patients with edema undergoing rapid diuresis lost more weight (1.8 +/- 0.5 kg/day, p = 0.06) but less ascites (0.7 +/- 0.35 L/day, p less than 0.05) than those without edema, and none developed renal insufficiency. After edema disappeared, ascites mobilization increased (1.4 +/- 0.7 L/day) and renal dysfunction occurred. Plasma volume fell an average of 24% +/- 9% in patients without edema but did not change in patients with edema (-0.4% +/- 3%). When edema disappeared, plasma volume fell significantly (28% +/- 8%, p less than 0.001). Electrolyte changes including hyponatremia, hyperkalemia, and hypochloremia were seen only in the group without edema. Patients with ascites and no edema are able to mobilize more than 1 L/day during rapid diuresis, but at the expense of plasma volume contraction and renal insufficiency. Patients with peripheral edema appear to be protected from these effects because of the preferential mobilization of edema and may safely undergo diuresis at a rapid rate (greater than 2 kg/day) until edema disappears.

摘要

对14例病情稳定的慢性肝病患者使用大剂量口服利尿剂治疗期间,进行了血浆容量和腹水量的系列测量。8例患者除腹水外还有凹陷性水肿。在10名未接受利尿剂治疗的对照受试者中验证了腹水和血浆容量测量的可重复性。6例无水肿的患者进行快速利尿时,平均每天腹水减少1.2±0.2L,体重减轻相当量(1.3±0.4kg)。所有患者血尿素氮或肌酐或两者均升高,肌酐清除率下降。8例有水肿的患者进行快速利尿时,体重减轻更多(1.8±0.5kg/天,p = 0.06),但腹水减少较少(0.7±0.35L/天,p<0.05),且均未发生肾功能不全。水肿消失后,腹水消退增加(1.4±0.7L/天),并出现肾功能障碍。无水肿患者的血浆容量平均下降24%±9%,但有水肿患者的血浆容量无变化(-0.4%±3%)。当水肿消失时,血浆容量显著下降(28%±8%,p<0.001)。电解质变化包括低钠血症、高钾血症和低氯血症仅见于无水肿组。有腹水但无水肿的患者在快速利尿期间每天能够排出超过1L的腹水,但代价是血浆容量收缩和肾功能不全。有外周水肿的患者似乎因水肿优先消退而免受这些影响,并且可以安全地以快速速率(>2kg/天)进行利尿,直到水肿消失。

相似文献

1
Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.慢性肝病腹水患者的快速利尿:外周水肿的重要性。
Gastroenterology. 1986 Jun;90(6):1827-33. doi: 10.1016/0016-5085(86)90249-0.
2
Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.用尿素治疗对利尿剂耐药的低钠血症性肝硬化腹水
Nephron. 1986;44(4):337-43. doi: 10.1159/000184016.
3
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.经颈静脉肝内门体分流术治疗顽固性肝腹水的肾脏及血流动力学效应
Gastroenterology. 1979 Aug;77(2):250-7.
4
Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration.肝硬化患者腹水动力学:快速扩容及利尿剂应用的影响
J Lab Clin Med. 1988 Feb;111(2):166-72.
5
The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.单次静脉注射布美他尼与呋塞米对酒精性肝病所致腹水和水肿患者的影响。
J Clin Pharmacol. 1981 Nov-Dec;21(11):706-11. doi: 10.1002/j.1552-4604.1981.tb05688.x.
6
An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.肝硬化腹水的最佳利尿方案。一项评估螺内酯和呋塞米安全性及疗效的对照试验。
JAMA. 1977 Mar 7;237(10):972-5.
7
Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis.肝硬化犬在使用呋塞米或甘露醇利尿后腹水的动员情况。
Am J Physiol. 1978 Jul;235(1):F12-21. doi: 10.1152/ajprenal.1978.235.1.F12.
8
[Clinical study of the use of "Spirolang" 50].["Spirolang" 50 使用的临床研究]
Minerva Med. 1971 Feb 28;62(17):816-27.
9
The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
Curr Med Res Opin. 1976;4(10):706-15. doi: 10.1185/03007997609112006.
10
Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics.使用利尿剂促使恶性腹水排出取决于腹水的特性。
Gastroenterology. 1992 Oct;103(4):1302-6. doi: 10.1016/0016-5085(92)91520-e.

引用本文的文献

1
CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PORTAL HYPERTENSION.克罗地亚门静脉高压诊断与治疗指南。
Acta Clin Croat. 2024 Apr;63(1):214-243. doi: 10.20471/acc.2024.63.01.26.
2
An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic.加拿大肝脏研究协会关于2019冠状病毒病大流行期间肝病管理的最新情况。
Can Liver J. 2020 Nov 17;3(4):309-321. doi: 10.3138/canlivj-2020-0013. eCollection 2020 Fall.
3
Management of Ascites in Patients with Cirrhosis: An Update.
肝硬化患者腹水的管理:最新进展
J Clin Med. 2021 Nov 10;10(22):5226. doi: 10.3390/jcm10225226.
4
Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians.肝硬化腹水的优化管理:内科医师综述
J Transl Int Med. 2020 Dec 31;8(4):220-236. doi: 10.2478/jtim-2020-0035. eCollection 2020 Dec.
5
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南。
Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16.
6
Approach and management of dysnatremias in cirrhosis.肝硬化伴电解质紊乱的处理方法。
Hepatol Int. 2018 Nov;12(6):487-499. doi: 10.1007/s12072-018-9894-6. Epub 2018 Sep 10.
7
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.《肝硬化腹水及相关并发症的KASL临床实践指南》
Clin Mol Hepatol. 2018 Sep;24(3):230-277. doi: 10.3350/cmh.2018.1005. Epub 2018 Jul 9.
8
Clinical Features of Refractory Ascites in Outpatients.门诊难治性腹水的临床特征
Clinics (Sao Paulo). 2017 Jul;72(7):405-410. doi: 10.6061/clinics/2017(07)03.
9
Ascites, refractory ascites and hyponatremia in cirrhosis.肝硬化中的腹水、顽固性腹水和低钠血症
Gastroenterol Rep (Oxf). 2017 May;5(2):104-112. doi: 10.1093/gastro/gox010. Epub 2017 Apr 24.
10
Hyponatremia in Patients with Cirrhosis of the Liver.肝硬化患者的低钠血症
J Clin Med. 2014 Dec 31;4(1):85-101. doi: 10.3390/jcm4010085.